HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 828

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

    Article Cited by others


Conjugate pneumococcal vaccines: Need and choice in India

Malik Akash, Taneja D K

Year : 2013| Volume: 38| Issue : 4 | Page no: 189-191

   This article has been cited by
1 A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India
Jugesh Chhatwal, Amita Sapru, Balasubramanian Sundaram, Bhaskar Shenoy, Rohit Chand, Kevin Yi, Suresh Suroju, Daniel A. Scott, Stephen Lockhart
Vaccine. 2021; 39(37): 5313
[Pubmed]  [Google Scholar] [DOI]
2 Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study
Sanjay Kewalchand Lalwani, Padmasani Venkat Ramanan, Amita Sapru, Balasubramanian Sundaram, Bela Hasmukh Shah, Dinesh Kaul, N. Karthik Nagesh, Warren V. Kalina, Rohit Chand, Meichun Ding, Suresh Suroju, Daniel A. Scott, Stephen P. Lockhart
Vaccine. 2021; 39(46): 6787
[Pubmed]  [Google Scholar] [DOI]
3 Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 617 Years of Age in India
Sharad Agarkhedkar,Christine Juergens,Krishnamurthy Balasundaram,Shalaka Agarkhedkar,Vani Sundaraiyer,Natacha Le Dren-Narayanin,Mark W. Cutler,William C. Gruber,Daniel A. Scott,Beate Schmoele-Thoma
The Pediatric Infectious Disease Journal. 2017; 36(11): e283
[Pubmed]  [Google Scholar] [DOI]


Read this article
  Sitemap | What's New | Feedback | Copyright and Disclaimer
  2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007